Philippe Moreillon

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


191 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1991 | 1990 | 1988 | 1987 | 1986 | 1985 | 1983 |
Genotypes of Staphylococcus aureus: On-farm epidemiology and the consequences for prevention of intramammary infections.
Leuenberger A., Sartori C., Boss R., Resch G., Oechslin F., Steiner A., Moreillon P., Graber H.U., 2019/04. Journal of dairy science, 102 (4) pp. 3295-3309. Peer-reviewed.
 
Assessment of the Dual Role of Clumping Factor A in S. Aureus Adhesion to Endothelium in Absence and Presence of Plasma.
Claes J., Ditkowski B., Liesenborghs L., Veloso T.R., Entenza J.M., Moreillon P., Vanassche T., Verhamme P., Hoylaerts M.F., Heying R., 2018/07. Thrombosis and haemostasis, 118 (7) pp. 1230-1241. Peer-reviewed.
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.
Larpin Y., Oechslin F., Moreillon P., Resch G., Entenza J.M., Mancini S., 2018. PloS one, 13 (2) pp. e0192507. Peer-reviewed.
 
Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations.
Mancini S., Oechslin F., Menzi C., Que Y.A., Claes J., Heying R., Veloso T.R., Vanassche T., Missiakas D., Schneewind O. et al., 2018. Virulence, 9 (1) pp. 1615-1624. Peer-reviewed.
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
Oechslin F., Piccardi P., Mancini S., Gabard J., Moreillon P., Entenza J.M., Resch G., Que Y.A., 2017/03/01. The Journal of infectious diseases, 215 (5) pp. 703-712. Peer-reviewed.
 
Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.
Guignard B., Majcherczyk P.A., Monachon C., Vouillamoz J., Moreillon P., 2017. International Journal of Antimicrobial Agents, 49 (1) pp. 53-61. Peer-reviewed.
Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.
Mancini S., Menzi C., Oechslin F., Moreillon P., Entenza J.M., 2016/12. Infection and immunity, 84 (12) pp. 3557-3563. Peer-reviewed.
 
Development of Potent and Selective S. aureus Sortase A Inhibitors Based on Peptide Macrocycles.
Rentero Rebollo I., McCallin S., Bertoldo D., Entenza J.M., Moreillon P., Heinis C., 2016. ACS Medicinal Chemistry Letters, 7 (6) pp. 606-611. Peer-reviewed.
 
In vitro and in vivo effectiveness of an innovative silver-copper nanoparticle coating of catheters to prevent methicillin-resistant Staphylococcus aureus infection
Ballo Myriam K.S., Rtimi Sami, Pulgarin César, Hopf Nancy, Berthet Aurélie, Kiwi John, Moreillon Philippe, Entenza José M., Bizzini Alain, 2016. Antimicrobial Agents and Chemotherapy, 60 (9) pp. 5349-5356. Peer-reviewed.
Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.
Veloso T.R., Oechslin F., Que Y.A., Moreillon P., Entenza J.M., Mancini S., 2015. Pathogens and Disease, 73 (8) pp. ftv060.
Excision of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus assessed by quantitative PCR.
Stojanov M., Moreillon P., Sakwinska O., 2015. Bmc Research Notes, 8 p. 828. Peer-reviewed.
 
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
Del Río A., García-de-la-Mària C., Entenza J.M., Gasch O., Armero Y., Soy D., Mestres C.A., Pericás J.M., Falces C., Ninot S. et al., 2015. Antimicrobial Agents and Chemotherapy, 60 (1) pp. 478-486.
 
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.
Chirouze C., Alla F., Fowler V.G., Sexton D.J., Corey G.R., Chu V.H., Wang A., Erpelding M.L., Durante-Mangoni E., Fernández-Hidalgo N. et al., 2015. Clinical Infectious Diseases, 60 (5) pp. 741-749.
 
In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.
Mancini S., Laurent F., Veloso T.R., Giddey M., Vouillamoz J., Vandenesch F., Moreillon P., Entenza J.M., 2015. Antimicrobial Agents and Chemotherapy, 59 (4) pp. 2435-2438.
Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents : a role for long-term prevention of infective endocarditis in humans?
Veloso T.R., Que Y.A., Chaouch A., Giddey M., Vouillamoz J., Rousson V., Moreillon P., Entenza J.M., 2015. Journal of Infectious Diseases, 211 (1) pp. 72-79. Peer-reviewed.
Reply to Eisen and McBryde.
Veloso T.R., Que Y.A., Moreillon P., Entenza J.M., 2015. Journal of Infectious Diseases, 212 (4) pp. 674-675. Peer-reviewed.
 
Staphylococcus aureus (Including Staphylococcal toxic shock)
Que Y.A., Moreillon P., 2015. pp. 2237-2271 dans Bennett J.E., Dolin R., Blaser M.J. (eds.) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases chap. 195, Saunders.
 
Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso T.R., Mancini S., Giddey M., Vouillamoz J., Que Y.A., Moreillon P., Entenza J.M., 2015. Vaccine, 33 (30) pp. 3512-3517. Peer-reviewed.
 
Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., Mancini S., 2014. Journal of Global Antimicrobial Resistance, 2 (4) pp. 306-308. Peer-reviewed.
A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus.
Guignard B., Vouillamoz J., Giddey M., Moreillon P., 2013. European Journal of Clinical Microbiology and Infectious Diseases, 32 (7) pp. 899-907.
 
Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
Vouillamoz J., Entenza J.M., Giddey M., Fischetti V.A., Moreillon P., Resch G., 2013. International Journal of Antimicrobial Agents, 42 (5) pp. 416-421.
 
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
Chirouze C., Athan E., Alla F., Chu V.H., Ralph Corey G., Selton-Suty C., Erpelding M.L., Miro J.M., Olaison L., Hoen B. et al., 2013. Clinical Microbiology and Infection, 19 (12) pp. 1140-1147.
Expression of SCCmec cassette chromosome recombinases in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Stojanov M., Sakwinska O., Moreillon P., 2013. Journal of Antimicrobial Chemotherapy, 68 (4) pp. 749-757.
 
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
Chambers S.T., Murdoch D., Morris A., Holland D., Pappas P., Almela M., Fernández-Hidalgo N., Almirante B., Bouza E., Forno D. et al., 2013. PLoS One, 8 (5) pp. e63181.
Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome.
Resch G., François P., Morisset D., Stojanov M., Bonetti E.J., Schrenzel J., Sakwinska O., Moreillon P., 2013. PLoS One, 8 (3) pp. e58187.
 
In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.
Oechslin F., Daraspe J., Giddey M., Moreillon P., Resch G., 2013. Antimicrobial Agents and Chemotherapy, 57 (12) pp. 6276-6283.
 
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.
Lalani T., Chu V.H., Park L.P., Cecchi E., Corey G.R., Durante-Mangoni E., Fowler V.G., Gordon D., Grossi P., Hannan M. et al., 2013. JAMA Internal Medicine, 173 (16) pp. 1495-1504.
 
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke.
Barsic B., Dickerman S., Krajinovic V., Pappas P., Altclas J., Carosi G., Casabé J.H., Chu V.H., Delahaye F., Edathodu J. et al., 2013. Clinical Infectious Diseases, 56 (2) pp. 209-217.
 
Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.
Veloso T.R., Zbinden A., Andreoni F., Giddey M., Vouillamoz J., Moreillon P., Zinkernagel A.S., Entenza J.M., 2013. International Journal of Medical Microbiology, 303 (8) pp. 498-504. Peer-reviewed.
 
Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.
Veloso T.R., Chaouch A., Roger T., Giddey M., Vouillamoz J., Majcherczyk P., Que Y.A., Rousson V., Moreillon P., Entenza J.M., 2013. Infection and Immunity, 81 (3) pp. 697-703. Peer-reviewed.
Daptomycin for highly resistant Enterococcus faecium infection.
Rosin C., Bernsmeier C., Entenza J.M., Moreillon P., Frei R., Weisser M., Flückiger U., 2012/06/26. Swiss medical weekly, 142 pp. w13603. Peer-reviewed.
Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs
Oppliger Anne, Moreillon Philippe, Charrière Nicole, Giddey Marlyse, Morisset Delphine, Sakwinska Olga, 2012. Applied and Environmental Microbiology, 78 (22) pp. 8010-8014. Peer-reviewed.
 
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.
Athan E., Chu V.H., Tattevin P., Selton-Suty C., Jones P., Naber C., Miró J.M., Ninot S., Fernández-Hidalgo N., Durante-Mangoni E. et al., 2012. Journal of the American Medical Association, 307 (16) pp. 1727-1735.
Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response.
Dengler V., Meier P.S., Heusser R., Kupferschmied P., Fazekas J., Friebe S., Staufer S.B., Majcherczyk P.A., Moreillon P., Berger-Bächi B. et al., 2012. FEMS Microbiology Letters, 333 (2) pp. 109-120.
 
Evidence for a new post-translational modification in Staphylococcus aureus: Hydroxymethylation of asparagine and glutamine.
Waridel P., Ythier M., Gfeller A., Moreillon P., Quadroni M., 2012. Journal of Proteomics, 75 (6) pp. 1742-1751.
 
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró J.M., Entenza J.M., Del Río A., Velasco M., Castañeda X., Garcia de la Mària C., Giddey M., Armero Y., Pericàs J.M., Cervera C. et al., 2012. Antimicrobial Agents and Chemotherapy, 56 (8) pp. 4511-4515. Peer-reviewed.
 
Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.
Ythier M., Resch G., Waridel P., Panchaud A., Gfeller A., Majcherczyk P., Quadroni M., Moreillon P., 2012. Molecular and Cellular Proteomics, 11 (11) pp. 1123-1139. Peer-reviewed.
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
Moreillon P., Bizzini A., Giddey M., Vouillamoz J., Entenza J.M., 2012. Journal of Antimicrobial Chemotherapy, 67 (3) pp. 652-660.
 
A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance.
Resch G., Moreillon P., Fischetti V.A., 2011. International Journal of Antimicrobial Agents, 38 (6) pp. 516-521.
 
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.
Kiefer T., Park L., Tribouilloy C., Cortes C., Casillo R., Chu V., Delahaye F., Durante-Mangoni E., Edathodu J., Falces C. et al., 2011. JAMA, 306 (20) pp. 2239-2247.
 
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Pea F., Cojutti P., Petrosillo N., Furlanut M., Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (9) pp. 4496; author reply 4496-4496; author reply 4497.
 
Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (1) pp. 385-387. Peer-reviewed.
 
In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Majcherczyk P., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (9) pp. 3977-3984.
 
Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.
Veloso T.R., Amiguet M., Rousson V., Giddey M., Vouillamoz J., Moreillon P., Entenza J.M., 2011. Infection and Immunity, 79 (5) pp. 2006-2011.
 
Infective endocarditis.
Que Y.A., Moreillon P., 2011. Nature Reviews. Cardiology, 8 (6) pp. 322-336.
 
Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing Swiss and French isolates from the Rhône Valley.
Sakwinska O., Morisset D., Madec J.Y., Waldvogel A., Moreillon P., Haenni M., 2011. Applied and Environmental Microbiology, 77 (10) pp. 3428-3432.
 
Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins.
Nienaber J.J., Sharma Kuinkel B.K., Clarke-Pearson M., Lamlertthon S., Park L., Rude T.H., Barriere S., Woods C.W., Chu V.H., Marín M. et al., 2011. Journal of Infectious Diseases, 204 (5) pp. 704-713.
Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis.
Danne C., Entenza J.M., Mallet A., Briandet R., Débarbouillé M., Nato F., Glaser P., Jouvion G., Moreillon P., Trieu-Cuot P. et al., 2011. Journal of Infectious Diseases, 204 (12) pp. 1960-1970.
PEGylating a bacteriophage endolysin inhibits its bactericidal activity.
Resch G., Moreillon P., Fischetti V.A., 2011. AMB Express, 1 p. 29.
 
Staphylococcus aureus host range and human-bovine host shift.
Sakwinska O., Giddey M., Moreillon M., Morisset D., Waldvogel A., Moreillon P., 2011. Applied and Environmental Microbiology, 77 (17) pp. 5908-5915.
 
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
Bizzini A., Entenza J.M., Michielin O., Arnold I., Erni B., Moreillon P., 2010. Antimicrobial Agents and Chemotherapy, 54 (1) pp. 259-266.
Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis.
Buck A.W., Fowler V.G., Yongsunthon R., Liu J., DiBartola A.C., Que Y.A., Moreillon P., Lower S.K., 2010. Langmuir, 26 (13) pp. 10764-10770.
 
Ecological temporal stability of Staphylococcus aureus nasal carriage.
Sakwinska O., Blanc D.S., Lazor-Blanchet C., Moreillon M., Giddey M., Moreillon P., 2010. Journal of Clinical Microbiology, 48 (8) pp. 2724-2728.
 
Endocarditis and endarteritis
Moreillon P., 2010. pp. 514-528 dans Cohen J., Opal S.M., Powderly W.G. (eds.) Infectious diseases chap. 47, Mosby.
 
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., 2010. International Journal of Antimicrobial Agents, 35 (5) pp. 451-456.
 
MRSA ST398 in Switzerland : not only colonization of pigs and pig workers but also cow mastitis
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Morisset Delphine, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2010. pp. ENA-1 dans Immunology and Cancer, CHUV Research Day, January 28, 2010, CHUV Research Day, Université de Lausanne, Faculté de biologie et de médecine.
 
Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus.
Ythier M., Entenza J.M., Bille J., Vandenesch F., Bes M., Moreillon P., Sakwinska O., 2010. Infection and Immunity, 78 (4) pp. 1711-1716.
 
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.
Haenni M., Galofaro L., Ythier M., Giddey M., Majcherczyk P., Moreillon P., Madec J.Y., 2010. Antimicrobial Agents and Chemotherapy, 54 (3) pp. 1140-1145.
Prospective monitoring of cefepime in intensive care unit adult patients.
Chapuis T.M., Giannoni E., Majcherczyk P.A., Chioléro R., Schaller M.D., Berger M.M., Bolay S., Décosterd L.A., Bugnon D., Moreillon P., 2010. Critical Care, 14 (2) pp. R51.
 
Staphylococcus aureus (Including Staphylococcal Toxic Shock)
Que Y.A., Moreillon P., 2010. pp. 2543-2578 dans Mandell G.L., Bennett J.E., Dolin R. (eds.) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases chap. 195, Churchill Livingstone Elsevier.
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.
Murdoch D.R., Corey G.R., Hoen B., Miró J.M., Fowler V.G., Bayer A.S., Karchmer A.W., Olaison L., Pappas P.A., Moreillon P. et al., 2009/03/09. Archives of internal medicine, 169 (5) pp. 463-473. Peer-reviewed.
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.
Naber C.K., Baddour L.M., Giamarellos-Bourboulis E.J., Gould I.M., Herrmann M., Hoen B., Karchmer A.W., Kobayashi Y., Kozlov R.S., Lew D. et al., 2009. Clinical infectious diseases, 48 Suppl 4 pp. S260-S270.
 
Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells.
Heying R., van de Gevel J., Que Y.A., Piroth L., Moreillon P., Beekhuizen H., 2009. Thrombosis and Haemostasis, 101 (3) pp. 495-504. Peer-reviewed.
 
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
Entenza J.M., Haldimann A., Giddey M., Lociuro S., Hawser S., Moreillon P., 2009. Antimicrobial Agents and Chemotherapy, 53 (9) pp. 3635-3641.
 
Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans.
Sakwinska O., Kuhn G., Balmelli C., Francioli P., Giddey M., Perreten V., Riesen A., Zysset F., Blanc D.S., Moreillon P., 2009. Applied and Environmental Microbiology, 75 (1) pp. 175-183. Peer-reviewed.
 
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.
Habib G., Hoen B., Tornos P., Thuny F., Prendergast B., Vilacosta I., Moreillon P., de Jesus Antunes M., Thilen U., Lekakis J. et al., 2009. European Heart Journal, 30 (19) pp. 2369-2413.
 
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.
Benito N., Miró J.M., de Lazzari E., Cabell C.H., del Río A., Altclas J., Commerford P., Delahaye F., Dragulescu S., Giamarellou H. et al., 2009. Annals of Internal Medicine, 150 (9) pp. 586-594.
M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island.
Panchaud A., Guy L., Collyn F., Haenni M., Nakata M., Podbielski A., Moreillon P., Roten C.A., 2009. BMC genomics, 10 p. 198. Peer-reviewed.
 
MRSA ST398 in Switzerland : not only colonization of pigs and pig workers but also cow mastitis
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Morisset Delphine, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2009. pp. 18B, 34 dans Methicillin-Resistant Staphylococci in Animals : veterinary and public health implications : ASM Conferences, September 22-25, 2009, London, England, American Society for Microbiology.
Patients at risk of complications of Staphylococcus aureus bloodstream infection.
del Rio A., Cervera C., Moreno A., Moreillon P., Miró J.M., 2009. Clinical Infectious Diseases, 48 Suppl 4 pp. S246-S253.
 
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
Entenza J.M., Moreillon P., 2009. International Journal of Antimicrobial Agents, 34 (1) pp. 8.e1-8.e9.
 
Transmission of MRSA and MSSA between humans and farm animals
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2009. pp. P050, 110 dans Microbes rule the world : 68th Annual Assembly of the SSM, Amphipôle, University of Lausanne, 4-5 June, 2009, Swiss Society for Microbiology.
 
ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups
Panchaud A., Hansson J., Affolter M., Bel R. R., Piu S., Moreillon P., Kussmann M., 2008. Molecular and Cellular Proteomics, 7 (4) pp. 800-812. Peer-reviewed.
 
Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project
Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.B., Entenza J.M., Moreillon P., Wind R.D., Knol J. et al., 2008. Trends in Food Science and Technology, 19 (2) pp. 102-114. Peer-reviewed.
 
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.
Durante-Mangoni E., Bradley S., Selton-Suty C., Tripodi M.F., Barsic B., Bouza E., Cabell C.H., Ramos A.I., Fowler V., Hoen B. et al., 2008. Archives of Internal Medicine, 168 (19) pp. 2095-2103.
 
Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis.
Majcherczyk P.A., Barblan J.L., Moreillon P., Entenza J.M., 2008. Microbial pathogenesis, 45 (5-6) pp. 408-414. Peer-reviewed.
 
Experimental and computational approaches to quantitative proteomics: status quo and outlook.
Panchaud A., Affolter M., Moreillon P., Kussmann M., 2008. Journal of Proteomics, 71 (1) pp. 19-33.
 
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory.
Haenni M., Moreillon P., 2008. Antimicrobial Agents and Chemotherapy, 52 (1) pp. 337-339.
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2008. Journal of Antimicrobial Chemotherapy, 61 (2) pp. 371-374.
 
New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
Moreillon P., 2008. Clinical Microbiology and Infection, 14 (Suppl. 3) pp. 32-41. Peer-reviewed.
 
The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis.
Piroth L., Que Y.A., Widmer E., Panchaud A., Piu S., Entenza J.M., Moreillon P., 2008. Infection and Immunity, 76 (8) pp. 3824-3831.
 
Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii.
Bizzini A., Majcherczyk P., Beggah-Möller S., Soldo B., Entenza J.M., Gaillard M., Moreillon P., Lazarevic V., 2007. Microbiology, 153 (Pt 2) pp. 490-498.
 
Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells.
Heying R., van de Gevel J., Que Y.A., Moreillon P., Beekhuizen H., 2007. Thrombosis and haemostasis, 97 (4) pp. 617-26. Peer-reviewed.
 
Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis.
Vankerckhoven V., Moreillon P., Piu S., Giddey M., Huys G., Vancanneyt M., Goossens H., Entenza J.M., 2007. Journal of Medical Microbiology, 56 (8) pp. 1017-1024.
Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii.
Bizzini A., Entenza J.M., Moreillon P., 2007. Journal of Antimicrobial Chemotherapy, 59 (4) pp. 607-615.
 
Mass spectrometry as a rapid and powerful alternative to antibodies for detecting LPXTG wall-associated proteins of Staphylococcus aureus
Panchaud A., Widmer E., Kussmann M., Moreillon P., Affolter M., 2007. International Journal of Mass Spectrometry, 268 (2-3) pp. 234-243. Peer-reviewed.
 
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii.
Haenni M., Moreillon P., Lazarevic V., 2007. Antimicrobial Agents and Chemotherapy, 51 (8) pp. 2774-2783.
 
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
Moreillon P., Wilson W.R., Leclercq R., Entenza J.M., 2007. Antimicrobial Agents and Chemotherapy, 51 (5) pp. 1661-1665.
 
Combining protein identification and quantification: C-terminal isotope-coded tagging using sulfanilic acid.
Panchaud A., Guillaume E., Affolter M., Robert F., Moreillon P., Kussmann M., 2006. Rapid Communications in Mass Spectrometry, 20 (10) pp. 1585-1594.
 
Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA.
Aellen S., Que Y.A., Guignard B., Haenni M., Moreillon P., 2006. Antimicrobial Agents and Chemotherapy, 50 (6) pp. 1913-1920.
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2006. Journal of Antimicrobial Chemotherapy, 58 (6) pp. 1208-1214.
 
Granular layer in the periplasmic space of gram-positive bacteria and fine structures of Enterococcus gallinarum and Streptococcus gordonii septa revealed by cryo-electron microscopy of vitreous sections.
Zuber B., Haenni M., Ribeiro T., Minnig K., Lopes F., Moreillon P., Dubochet J., 2006. Journal of Bacteriology, 188 (18) pp. 6652-6660.
 
Infective endocarditis in the elderly
Moreillon P., Bizzini A., Que Y. A., 2006. pp. 1749-1762 dans Patty J.M.S., Sinclair A.J., Morley J.E. (eds.) Principles and Practice of Geriatric Medicine chap. 147, John Wiley & Sons.
 
L'endocardite en pratique ambulatoire [Infective endocarditis and outpatient practice].
Que Y.A., Moreillon P., Francioli P., 2006. Revue Médicale Suisse, 2 (60) pp. 903-6, 908-11.
 
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis.
Bizzini A., Beggah-Möller S., Moreillon P., Entenza J.M., 2006. FEMS Immunology and Medical Microbiology, 48 (3) pp. 419-423.
 
Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii.
Haenni M., Majcherczyk P.A., Barblan J.L., Moreillon P., 2006. Antimicrobial Agents and Chemotherapy, 50 (12) pp. 4062-4069.
 
Mutations in penicillin-binding protein (PBP) genes and in non-PBP genes during selection of penicillin-resistant Streptococcus gordonii.
Haenni M., Moreillon P., 2006. Antimicrobial Agents and Chemotherapy, 50 (12) pp. 4053-4061.
New concepts in the pathophysiology of infective endocarditis.
Widmer E., Que Y.A., Entenza J.M., Moreillon P., 2006. Current Infectious Disease Reports, 8 (4) pp. 271-279.
 
Prospective determination of plasma imipenem concentrations in critically ill children.
Giannoni E., Moreillon P., Cotting J., Moessinger A., Bille J., Décosterd L., Zanetti G., Majcherczyk P., Bugnon D., 2006. Antimicrobial Agents and Chemotherapy, 50 (7) pp. 2563-2568.
The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus.
Majcherczyk P.A., McKenna T., Moreillon P., Vaudaux P., 2006. FEMS Microbiology Letters, 255 (2) pp. 233-239.
 
Beta-lactams against methicillin-resistant Staphylococcus aureus.
Guignard B., Entenza J.M., Moreillon P., 2005. Current Opinion in Pharmacology, 5 (5) pp. 479-489.
 
Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains.
Rigoulay C., Entenza J.M., Halpern D., Widmer E., Moreillon P., Poquet I., Gruss A., 2005. Infection and Immunity, 73 (1) pp. 563-572.
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis.
Que Y.A., Haefliger J.A., Piroth L., François P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P. et al., 2005. Journal of Experimental Medicine, 201 (10) pp. 1627-1635. Peer-reviewed.
Genometrics as an essential tool for the assembly of whole genome sequences: the example of the chromosome of Bifidobacterium longum NCC2705.
Guy L., Karamata D., Moreillon P., Roten C.A., 2005. BMC Microbiology, 5 p. 60.
 
Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis.
Entenza J.M., Moreillon P., Senn M.M., Kormanec J., Dunman P.M., Berger-Bächi B., Projan S., Bischoff M., 2005. Infection and Immunity, 73 (2) pp. 990-998.
 
Staphylococcus aureus (Including Staphylococcal Toxic Shock)
Moreillon P., Que Y. A., Glauser M. P., 2005. pp. 2321-2351 dans Mandell G. L., Bennett J. E., Dolin R. (eds.) Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases chap. 192, Churchill Livingstone.
 
Structure-function characterization and optimization of a plant-derived antibacterial peptide.
Suarez M., Haenni M., Canarelli S., Fisch F., Chodanowski P., Servis C., Michielin O., Freitag R., Moreillon P., Mermod N., 2005. Antimicrobial Agents and Chemotherapy, 49 (9) pp. 3847-3857.
 
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats.
Entenza J.M., Loeffler J.M., Grandgirard D., Fischetti V.A., Moreillon P., 2005. Antimicrobial Agents and Chemotherapy, 49 (11) pp. 4789-4792.
 
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 2004. Antimicrobial Agents and Chemotherapy, 48 (1) pp. 86-92.
 
Endocardite infectieuse: mise au point [Infective endocarditis: update]
Que Y.A., Oddo M., Liaudet L., Moreillon P., 2004. Revue Médicale de la Suisse Romande, 124 (6) pp. 341-346.
 
Infective endocarditis.
Moreillon P., Que Y.A., 2004. Lancet, 363 (9403) pp. 139-149.
 
Inflammation and host defense
Majcherczyk P. A., Moreillon P., 2004. pp. 183-200 dans Tuomanen E. I., Mitchell T. J., Morison D. A., Spratt B. G. (eds.) The Pneumococcus chap. 12, ASM Press.
 
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
Vouillamoz J., Entenza J.M., Hohl P., Moreillon P., 2004. Antimicrobial Agents and Chemotherapy, 48 (11) pp. 4322-4327.
 
Antibiotic-dependent correlation between drug-induced killing and loss of luminescence in Streptococcus gordonii expressing luciferase.
Loeliger B., Caldelari I., Bizzini A., Stutzmann Meier P., Majcherczyk P.A., Moreillon P., 2003. Microbial Drug Resistance, 9 (2) pp. 123-131.
 
Endocarditis and endarteritis
Moreillon P., 2003. dans Cohen J., Powderly W.G. (eds.) Infectious Diseases chap. 59, Mosby.
 
Expression of a plant-derived peptide harboring water-cleaning and antimicrobial activities.
Suarez M., Entenza J.M., Doerries C., Meyer E., Bourquin L., Sutherland J., Marison I., Moreillon P., Mermod N., 2003. Biotechnology and Bioengineering, 81 (1) pp. 13-20.
 
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
Marchetti O., Moreillon P., Entenza J.M., Vouillamoz J., Glauser M.P., Bille J., Sanglard D., 2003. Antimicrobial Agents and Chemotherapy, 47 (5) pp. 1565-1570.
 
Innate sensors for Gram-positive bacteria.
Weber J.R., Moreillon P., Tuomanen E.I., 2003. Current Opinion in Immunology, 15 (4) pp. 408-415.
 
Proinflammatory activity of cell-wall constituents from gram-positive bacteria.
Moreillon P., Majcherczyk P.A., 2003. Scandinavian Journal of Infectious Diseases, 35 (9) pp. 632-641.
 
Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytes.
Majcherczyk P.A., Rubli E., Heumann D., Glauser M.P., Moreillon P., 2003. Infection and Immunity, 71 (7) pp. 3707-3713.
 
The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis.
Cottagnoud P., Gerber C.M., Majcherczyk P.A., Acosta F., Cottagnoud M., Neftel K., Moreillon P., Täuber M.G., 2003. Infection and Immunity, 71 (6) pp. 3663-3666.
 
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
Entenza J.M., Hohl P., Heinze-Krauss I., Glauser M.P., Moreillon P., 2002. Antimicrobial Agents and Chemotherapy, 46 (1) pp. 171-177.
 
Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones.
Blanc D.S., Pittet D., Ruef C., Widmer A.F., Mühlemann K., Petignat C., Harbarth S., Auckenthaler R., Bille J., Frei R. et al., 2002. Clinical Microbiology and Infection, 8 (7) pp. 419-426. Peer-reviewed.
 
Pathogenesis of streptococcal and staphylococcal endocarditis.
Moreillon P., Que Y.A., Bayer A.S., 2002. Infectious Disease Clinics of North America, 16 (2) pp. 297-318.
 
Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro.
Bugnon D., Giannoni E., Majcherczyk P., Glauser M.P., Moreillon P., 2002. Antimicrobial Agents and Chemotherapy, 46 (11) pp. 3654-3656.
 
Prophylaxie de l'endocardite infectieuse : apport du modèle expérimental
Moreillon P., Dargère S., Piroth L., Entenza J. M., 2002. Médecine et Maladies Infectieuses, 32 (11) pp. 605-612. Peer-reviewed.
 
Résistance, virulence et fitness de Staphylococcus aureus.
Moreillon P, Entenza JM, 2002. pp. 109-126 dans Infection à l'hôpital: 2ème Journée Maurice Rapin - Aventis. Pneumocoques, staphylocoques actualités, Laboratoires Aventis.
 
Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography.
Majcherczyk P.A., Moreillon P., Decosterd L.A., Sanglard D., Bille J., Glauser M.P., Marchetti O., 2002. Journal of Pharmaceutical and Biomedical Analysis, 28 (3-4) pp. 645-651.
 
Traitments antibiotiques simplifies : l'exemple des infections des voies respiratoires supérieures
Moreillon P., Potin M., 2002. Médecine et Hygiène, 60 (2388) pp. 804-808.
 
Antibiotic resistance: learning from animal feeds and animal experimentation.
Moreillon P., Entenza J.M., 2001. Clinical Microbiology and Infection, 7 (Suppl. 5) pp. 13-18.
 
Apport des modèles expérimentaux: associations Synercid et beta-lactamines
Moreillon P., 2001. Presse Médicale, 30 (25 Pt 2) pp. X-XIV.
 
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis media.
Bochud P.Y., Calandra T., Moreillon P., Baumgartner J.D., Yersin B., 2001. European Journal of Clinical Microbiology and Infectious Diseases, 20 (2) pp. 136-137.
 
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza J.M., Que Y.A., Vouillamoz J., Glauser M.P., Moreillon P., 2001. Antimicrobial Agents and Chemotherapy, 45 (11) pp. 3076-3083.
 
Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.
Que Y.A., François P., Haefliger J.A., Entenza J.M., Vaudaux P., Moreillon P., 2001. Infection and Immunity, 69 (10) pp. 6296-6302.
 
Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.
Marchetti O., Majcherczyk P.A., Glauser M.P., Bille J., Moreillon P., Sanglard D., 2001. Antimicrobial Agents and Chemotherapy, 45 (3) pp. 696-700.
 
Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.
Stutzmann Meier P., Entenza J.M., Vaudaux P., Francioli P., Glauser M.P., Moreillon P., 2001. Infection and Immunity, 69 (2) pp. 657-664.
Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae.
Cottagnoud P., Entenza J.M., Cottagnoud M., Que Y.A., Moreillon P., Taüber M.G., 2001. BMC Microbiology, 1 p. 9.
 
Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus.
Entenza J.M., Foster T.J., Ni Eidhin D., Vaudaux P., Francioli P., Moreillon P., 2000. Infection and Immunity, 68 (9) pp. 5443-5446.
 
Deregulation of the arginine deiminase (arc) operon in penicillin-tolerant mutants of Streptococcus gordonii.
Caldelari I., Loeliger B., Langen H., Glauser M.P., Moreillon P., 2000. Antimicrobial Agents and Chemotherapy, 44 (10) pp. 2802-2810.
 
Endocarditis prophylaxis revisited: experimental evidence of efficacy and new Swiss recommendations. Swiss Working Group for Endocarditis Prophylaxis.
Moreillon P., 2000. Schweizerische Medizinische Wochenschrift, 130 (27-28) pp. 1013-1026.
 
Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector.
Que Y.A., Haefliger J.A., Francioli P., Moreillon P., 2000. Infection and Immunity, 68 (6) pp. 3516-3522.
 
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Marchetti O., Entenza J.M., Sanglard D., Bille J., Glauser M.P., Moreillon P., 2000. Antimicrobial Agents and Chemotherapy, 44 (11) pp. 2932-2938.
 
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells.
Sinha B., Francois P., Que Y.A., Hussain M., Heilmann C., Moreillon P., Lew D., Krause K.H., Peters G., Herrmann M., 2000. Infection and Immunity, 68 (12) pp. 6871-6878.
 
Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections?
Moreillon P., Majcherczyk P., 2000. International Journal of Clinical Practice. Supplement 115 pp. 99-105.
 
Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains.
Blanc D.S., Bañuls A.L., Hauser P.M., Moreillon P., Francioli P., Tibayrenc M., Swiss MRSA Group, 2000. Microbial Drug Resistance, 6 (3) pp. 231-238.
 
Moyens de défense des bactéries.
Moreillon P., 2000. Revue Médicale de la Suisse Romande, 120 (8) pp. 641-650.
 
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.
Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D., 2000. Antimicrobial Agents and Chemotherapy, 44 (9) pp. 2373-2381.
 
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
Vouillamoz J., Entenza J.M., Féger C., Glauser M.P., Moreillon P., 2000. Antimicrobial Agents and Chemotherapy, 44 (7) pp. 1789-1795.
 
Resistance to macrolides-lincosamides-streptogramins and ketolides in staphylococci and streptococci, and new therapeutic strategies.
Moreillon P., 2000. pp. 197-207 dans Zinner S.H., Young L.S., Acar J.F., Ortiz-Neu C. (eds.) New considerations for macrolides, azalides, streptogramines, and ketolides chap. III.3a, Marcel Dekker.
 
Résistance aux antibiotiques chez les pneumocoques [Pneumococcal antibiotic resistance].
Moreillon P., Wenger A., Caldelari I., 2000. Revue Médicale de la Suisse Romande, 120 (8) pp. 651-659.
 
Transfer of Staphylococcus aureus pathogenic genes into less virulent bacteria: a strategy to study virulence in experimental endocarditis.
Stutzmann-Meier P., Moriellon P., 2000. pp. 59-65 dans van Dissel J.T., van den Broek P.J. (eds.) Infectious diseases: on the threshold of the 21st century, Boerhaave Commissie.
 
Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity.
Majcherczyk P.A., Langen H., Heumann D., Fountoulakis M., Glauser M.P., Moreillon P., 1999. Journal of Biological Chemistry, 274 (18) pp. 12537-12543.
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Entenza J.M., Caldelari I., Glauser M.P., Moreillon P., 1999. Journal of Antimicrobial Chemotherapy, 44 (6) pp. 775-786.
 
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1999. Antimicrobial Agents and Chemotherapy, 43 (1) pp. 77-84.
 
Endocarditis and endarteritis
Moreillon P., 1999. pp. 50.1-50.10 dans Armstrong D., Cohen J. (eds.) Infectious Diseases chap. 50, Mosby.
Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence.
Blanc D.S., Petignat C., Moreillon P., Entenza J.M., Eisenring M., Kleiber H., Wenger A., Troillet N., Blanc C., Francioli P., 1999. Clinical Infectious Diseases, 29 (6) pp. 1512-1518.
 
Considérations générales sur les antibiotiques
Glauser M.P., Moreillon P., 1998. pp. 721-723 dans Schorderet M. (eds.) Pharmacologie: des concepts fondamentaux aux applications thérapeutiques, Frison-Roche ; Slatkine.
 
Généralités sur les antibiotiques de type bêtalactame.
Baumgartner J.D., Moreillon P., 1998. pp. 733-743 dans Schorderet M. (eds.) Pharmacologie: des concepts fondamentaux aux applications thérapeutiques, Frison-Roche; Slatkine.
The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Que Y.A., Entenza J.M., Francioli P., Moreillon P., 1998. Journal of Infectious Diseases, 177 (1) pp. 146-154.
 
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
Entenza J.M., Marchetti O., Glauser M.P., Moreillon P., 1998. Antimicrobial Agents and Chemotherapy, 42 (8) pp. 1889-1894.
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.
Entenza J.M., Caldelari I., Glauser M.P., Francioli P., Moreillon P., 1997. Journal of Infectious Diseases, 175 (1) pp. 70-76.
 
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1997. Antimicrobial Agents and Chemotherapy, 41 (8) pp. 1662-1667.
 
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.
Vermot D., Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1996. Antimicrobial Agents and Chemotherapy, 40 (3) pp. 809-811.
 
Peptidoglycane et protéines de liaison à la pénicilline chez les Staphylococcus aureus résistant à la méticilline.
Moreillon P., 1996. pp. 15-23 dans Étienne J., Goldstein F.W. (eds.) Les staphylocoques dorés résistants à la méticilline: aspects fondamentaux et cliniques, RPR Bellon.
 
Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing.
Blanc D.S., Petignat C., Moreillon P., Wenger A., Bille J., Francioli P., 1996. Infection Control and Hospital Epidemiology, 17 (10) pp. 654-659.
 
Résistance aux antibiotiques chez les pneumocoques.
Moreillon P., Wenger A., 1996. Schweizerische Medizinische Wochenschrift, 126 (7) pp. 255-263.
Amoxycillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections.
Moreillon P., 1995. Journal of Antimicrobial Chemotherapy, 35 (3) pp. 435-441.
 
La résistance bactérienne aux antibiotiques.
Moreillon P., 1995. Schweizerische Medizinische Wochenschrift, 125 (23) pp. 1151-1161.
 
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.
Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., François P., Vaudaux P., 1995. Infection and Immunity, 63 (12) pp. 4738-4743.
 
Role of the environment in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA).
Francioli P., Blanc D., Moreillon P., 1995. pp. 109-131 dans Brun-Buisson C. (eds.) Methicillin resistant staphylococci, Flammarion Medecine-Sciences.
 
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
L'Hériteau F., Entenza J.M., Lacassin F., Leport C., Glauser M.P., Moreillon P., 1995. Antimicrobial Agents and Chemotherapy, 39 (7) pp. 1425-1429.
 
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Entenza J.M., Drugeon H., Glauser M.P., Moreillon P., 1995. Antimicrobial Agents and Chemotherapy, 39 (7) pp. 1419-1424.
Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Entenza J.M., Fluckiger U., Glauser M.P., Moreillon P., 1994. Journal of Infectious Diseases, 170 (1) pp. 100-109.
 
Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
Entenza J.M., Blatter M., Glauser M.P., Moreillon P., 1994. Antimicrobial Agents and Chemotherapy, 38 (12) pp. 2683-2688.
Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci.
Fluckiger U., Francioli P., Blaser J., Glauser M.P., Moreillon P., 1994. Journal of Infectious Diseases, 169 (6) pp. 1397-1400.
 
Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.
Fluckiger U., Moreillon P., Blaser J., Bickle M., Glauser M.P., Francioli P., 1994. Antimicrobial Agents and Chemotherapy, 38 (12) pp. 2846-2849.
 
The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.
Moreillon P., 1994. Journal of Chemotherapy, 6 Suppl 2 pp. 51-57.
Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus.
Moreillon P., Franciolli M., Cantoni L., Bille J., Glauser M.P., 1991. Journal of Infectious Diseases, 163 (5) pp. 1165-1166.
Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
Franciolli M., Bille J., Glauser M.P., Moreillon P., 1991. Journal of Infectious Diseases, 163 (3) pp. 514-523.
 
Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms.
Moreillon P., Markiewicz Z., Nachman S., Tomasz A., 1990. Antimicrobial Agents and Chemotherapy, 34 (1) pp. 33-39.
 
Experimental endocarditis following dental extractions in rats with periodontitis.
Overholser C.D., Moreillon P., Glauser M.P., 1988. Journal of Oral and Maxillofacial Surgery, 46 (10) pp. 857-861.
 
Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae.
Tomasz A., Moreillon P., Pozzi G., 1988. Journal of Bacteriology, 170 (12) pp. 5931-5934.
 
Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.
Moreillon P., Tomasz A., 1988. Journal of Infectious Diseases, 157 (6) pp. 1150-1157.
Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease.
Moreillon P., Overholser C.D., Malinverni R., Bille J., Glauser M.P., 1988. Journal of Infectious Diseases, 157 (5) pp. 990-995.
 
The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.
Boelaert J.R., van Landuyt H.W., Valcke Y.J., Cantinieaux B., Lornoy W.F., Vanherweghem J.L., Moreillon P., Vandepitte J.M., 1987/08. Journal of Infectious Diseases, 156 (2) pp. 384-387.
Experimental bacterial endocarditis after dental extractions in rats with periodontitis.
Overholser C.D., Moreillon P., Glauser M.P., 1987. Journal of Infectious Diseases, 155 (1) pp. 107-112.
Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius.
Moreillon P., Francioli P., Overholser D., Meylan P., Glauser M.P., 1986. Journal of Infectious Diseases, 154 (5) pp. 801-807.
Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci.
Francioli P., Moreillon P., Glauser M.P., 1985. Journal of Infectious Diseases, 152 (1) pp. 83-89.
 
Prévalence des maladies infectieuses au Centre hospitalier universitaire vaudois [Prevalence of infectious diseases at the Vaud University Hospital Center].
Moreillon P., Broquet P.E., Bille J., Gloor E., Glauser M.P., 1985. Schweizerische Medizinische Wochenschrift, 115 (8) pp. 261-266.
 
Les infections endo-artérielles, complications redoutables des infections à salmonelles non typhi [Endarterial infections, redoubtable complications of non-typhi salmonella infections].
Moreillon P., Francioli P., Delacrétaz F., Weber J., Glauser M.P., 1983. Schweizerische Medizinische Wochenschrift, 113 (51) pp. 1953-1955.
Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection.
Glauser M.P., Bernard J.P., Moreillon P., Francioli P., 1983. Journal of Infectious Diseases, 147 (3) pp. 568-575.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University